Huino and Yuhan Corporation are supplying the smart artificial intelligence (AI) telemetry solution 'Memo Q' to the Department of Cardiology at Busan Veterans Hospital.


Smart AI Telemetry Solution 'Memo Q'. Huino

Smart AI Telemetry Solution 'Memo Q'. Huino

View original image

According to Huino on July 16, Memo Q is a smart AI telemetry solution that integrates the company's proprietary core technologies, including wearable biosignal measurement technology, AI-based biosignal analysis technology, and cloud-based remote monitoring service technology. Patients can move freely within the ward while wearing the ultra-compact wearable electrocardiograph 'MEMO Patch M', and medical staff can monitor vital sign data in real time without spatial or temporal constraints via the integrated control system monitor or mobile devices.


In particular, MEMO Patch M features a defibrillator-proof circuit, meeting the most stringent electrical safety standard, 'Type CF Defib-proof', under international medical device safety regulation IEC 60601-1. This enables continuous monitoring even during emergencies when a defibrillator is used, without the need to remove and re-attach the device—an important advantage.



Youngjun Gil, CEO of Huino, stated, "The supply to Busan Veterans Hospital is significant in that Memo Q is expanding its field applicability as a solution that meets the demand for monitoring high-risk patients in cardiology departments." He added, "Based on our ongoing partnership with Yuhan Corporation, we will continue to expand our supply, focusing on cardiology, while enhancing Memo Q as a digital healthcare solution that simultaneously improves patient safety and hospital operational efficiency."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing